We report the first case of Cryptococcus laurentii meningitis and a rare case of Cryptococcus albidus cryptococcaemia in AIDS patients. Both infections were treated with amphotericin B and flucytosine. The C. laurentii meningitis was controlled after 2 weeks of treatment with no evidence of infection 20 months later. The patient with C. albidus cryptococcaemia, despite the amphotericin B/flucytosine combination therapy, died on the 14th day of treatment. The minimum inhibitory concentrations (MICs) for C. laurentii, as determined by Etest on RPMI 1640 agar, were 0·25 g ml
Introduction only a few previously reported putative cases [4] [5] [6] [7] [8] of cryptococcoses due to C. albidus in immunoCryptococcosis is a serious infection often occurring compromised patients, and one case of septicaemia in in immunocompromised hosts and is frequently used an AIDS patient reported recently [9] . Although six synonymously with infection caused by Cryptococcus cases of C. albidus meningitis, some more adequately neoformans [1] . Recent reports have indicated an indocumented than others, have been published we were creasing incidence of the infection among patients with able to find only three previous reports on C. laurentii the acquired immunodeficiency syndrome (AIDS) [2, extrameningeal infection: one in an imunocompromised 3]. Despite the recognition of several species of the patient [10] , the second in a patient with chronic uveitis genus, the non-C. neoformans species are generally where C. laurentii was the aetiological agent of cryptoregarded as non-pathogenic saprophytes. There are coccal endophthalmitis [11] and the third in a bone marrow transplant recipient [12] . The former two cases have been the subject of dispute due mainly to the We describe two rare manifestations of cryptocurrently on triple antiretroviral therapy (Indinavir, coccosis due to non-C. neoformans species in AIDS lamivudine, ddC). patients. To our knowledge, there are no published reports on the isolation of C. laurentii from AIDS Mycology patients, and therefore it is believed that C. laurentii meningitis is the first reported case.
Cerebrospinal fluid (CSF) cultures on Sabouraud glucose agar (SGA) agar at 37°C revealed the presence of slow-growing hyaline colonies consisting of en- . The patient's haematocrit was 40·9%, C. laurentii reference strain (National Collection for haemoglobin was 13·1 g dl −1 , a leucocyte count of Pathogenic Fungi, Public Health Laboratory Service 4·7×10 9 l −1 with a differential of 65% neutrophils, 25% (PHLS), Bristol, UK) and all tests confirmed the idenlymphocytes and 10% monocytes; the platelet count tity of our isolate. The minimal inhibitory concentration was 360×10 9 l −1 and the CD4 count 99×10 6 l −1
. Au-(MICs) of antimycotic agents was determined using sculation of the lungs revealed rales bilaterally, mainly Etest (AB Biodisk, Solna, Sweden), according to the in the middle and the bases, and his chest radiography manufacturer's instructions on RPMI 1640 agar showed bilateral interstitial infiltrates. The patient had (Sigma, Deisennhofen, Germany), with -glutamine but signs of meningeal involvement and a lumbar puncture without bicarbonate, buffered with 0·165  morphowas performed. The cerebrospinal fluid (CSF) was clear, linopropanesulphonic acid (MOPS) (Sigma) at pH 7. the leucocyte count was 2×10 9 l −1 , protein=23 mg dl
The MIC of amphotericin B (AmB) was 0·25 g ml
, and glucose=0·51 g%. India ink preparations revealed flucytosine (FC) 1·25 g ml
, fluconazole (FL) the presence of encapsulated yeast cells, while five sets 4 g ml
, itraconazole (IT) 0·50 g ml −1 and of ketoof blood cultures were negative. He was immediately conazole (KE) 1·0 g ml
. started on intravenous amphotericin B (40 mg day
The amphotericin B MIC using Etest on Casitone agar and flucytosine (10 g day
), while treatment with zi-(Difco, Detroit, USA), buffered with phosphate buffer, dovudine (ZDV) and didanosine (ddI) was initiated.
was 0·19 g ml −1
. The microdilution method, according After 14 days of therapy fever and headache subsided, to the National Committee for Clinical Laboratory his diplopia improved, he started gaining weight and Standards (NCCLS) guidelines for drug concentrations his chest roentgenogram showed marked clearing. He and inoculum size [15] in antibiotic medium 3 (OXOID) was discharged 3 weeks later on fluconazole mainsupplemented with 2% glucose, revealed an amtenance treatment (200 mg day . most recent follow-up, March 1998, his roentgenogram
The quality control strains ATCC 90028 and 90018 MICs remained stable, and on physical examination no evidence of cryptococcal infection was detected. He is were 1·0 g ml −1 and 1·5 g ml
, respectively.
Case history 2
starch formation were positive and confirmed identification. On completion of identification, all tests were A 47-year-old Caucasian heterosexual female with run simultaneously with those for NCPF 38 C. albidus AIDS from the North West of Greece, whose HIV (PHLS, Bristol, UK) and the results confirmed the infection had been diagnosed in 1992 and whose CD4 identity of our isolate. Susceptibility testing was percount at that time was 220×10 6 l −1
, was receiving formed with Etest, as described previously. The MICs zidovudine treatment, to which ddI was added in Janrecorded were for AmB 0·5 g ml −1
, FC 1·5 g ml , IT 0·5 g ml −1 and KE 0·25 g ml −1
. The central nervous system toxoplasmosis (August 1995), amphotericin B MIC on casitone agar was 0·25 g ml −1
. wasting syndrome, fever of unknown aetiology and
The broth microdilution method [15] revealed an ammyelodysplastic syndrome (January 1996). In March photericin B MIC of 0·31 g ml −1 in antibiotic medium 1996 she presented with a 20-day history of high fever 2 supplemented with 2% glucose. (41°C). Her blood pressure at presentation was 90/ 70 mmHg, pulse 112 min fungal diseases are frequently reported [3] . However, The CSF cell count was 1×10 9 l −1 with normal protein reports of infection due to other species of Cryptococcus and glucose and the microscopic examination of CSF such as C. albidus, C. laurentii and C. luteolus are preparations with India ink was negative for enextremely rare [3] [4] [5] [6] [7] [8] [9] [10] [11] and poorly substantiated [13, 14] . capsulated yeast cells, while CSF cultures were negative.
In the present study evaluation of clinical data suggested Blood cultures revealed profuse growth of Cryptococcus that C. laurentii lung involvement could be associated spp. and antimycotic treatment with amphotericin B with meningeal infection. This observation has been (20 mg day −1 ) and flucytosine (5 g day
) was started reported for the first time in an AIDS patient. immediately. Despite the antifungal chemotherapy the It must be noted, however, that C. albidus is usually patient died on the 14th day of hospitalization.
isolated from the skin of healthy individuals and from indoor and outdoor air. In addition, C. laurentii is a saprobic organism and a known contaminant during Mycology the fermentation process of wine and beer [16] . Both Blood cultures repeated twice during the first week of these species have very rarely been reported to cause hospitalization revealed profuse growth of Cryptodisease [10, 11] . Despite the confirmed exclusive growth coccus spp. Five streak plates for the isolation of single of C. laurentii and C. albidus, precautions were taken colonies followed the initial isolation to exclude the in each case to exclude the possibility of contamination possibility of C. neoformans being present. All physioof clinical material through repeated isolation of the logical and biochemical tests confirmed that each of organisms from the clinical specimens. The likelihood the tested colonies had the same physiological charof the involvement of C. neoformans and the transient acters and carbon assimilation profiles compatible with presence of the saprobic non-C. neoformans species C. albidus.
in the clinical specimens were excluded by repeatedly On microscopic examination of the organism grown testing individual colonies from subsequent subcultures in malt extract agar for 3 days at 25°C, the yeast cells of the original isolates. All individual colonies demmeasured 5·5-7·2×8-9·2 m.
onstrated the same morphological and biochemical After 1 month at 20°C, the streak culture on malt characters conforming to those of C. laurentii and C. extract agar was tan, smooth, glossy and slimy with albidus, respectively. irregular border. No pseudomycelium was produced Unlike previously reported cases of fungaemia where on potato agar. The ability of the isolate to assimilate non-specific symptoms were described and laboratory a variety of carbohydrates was determined using the diagnosis was based on a single positive blood culture API ID 32 yeast identification system as described [6, 14] C. albidus fungaemia in this case was charpreviously. The species profile was compatible with acterized by typical symptoms and the organism was that of C. albidus in the API APILAB database. The isolated from two consecutive blood cultures. In previously reported cases no Cryptococcus-like cells were additional biochemical tests for nitrate assimilation and found in CSF [5, 10] . In the present case of C. laurentii 200 mg day −1 . In contrast our patient, who was infected with C. albidus, was at the latest stage of AIDS and meningitis typical encapsulated yeast cells were detected the C. albidus septicaemia was the terminal event. upon microscopic examination of CSF with India ink. This is the first time that non-C. neoformans clinical Moreover, both our isolates grew at 37°C upon inisolates have been evaluated as to their susceptibility cubation of the clinical samples. This is compatible to antifungals. Interestingly, the Etest MICs of amwith that recorded for most strains of C. albidus and photericin B on RPMI 1640 agar were higher, C. laurentii that can grow at 37°C [16] . It is noteworthy, 0·25 g ml −1 and 0·5 g ml −1 for C. laurentii and C. however, that after several subcultures both isolates albidus, respectively, that those recorded on Casitone grew poorly at 37°C and profusely at 28-30°C. medium (0·19 g ml −1 and 0·25 g ml ) for each Despite the repeated isolation of both non-C. neoCryptococcus species, respectively. The microdilution formans species from clinical material and their idenmethod performed in antibiotic medium 3 revealed tification with physiological and biochemical tests, it MIC values closer to those obtained by the Etest on was necessary to obtain further confirmation of idenCasitone medium, 0·15 g ml −1 and 0·37 g ml −1 for C. tification of the isolates by comparison of our isolates laurentii and C. albidus, respectively. This indicates that with reference strains. Both isolates were deposited to the agreement between the MIC values of amphotericin the National Collection of Pathogenic Fungi, at the B obtained on casitone medium by Etest and in anti-PHLS, Bristol, UK and were assigned the following biotic medium 3 by the microdilution method are in numbers: for C. laurentii NCPF 8225 and for C. albidus better agreement than those obtained by the Etest on NCPF 8249. Although C. albidus has been reported RPMI 1640. to share many biochemical characteristics and some Cryptococcosis attributable to non-C. neoformans capsular antigens with C. neoformans, cryptococcal species requires extensive investigation in order to be antigen latex agglutination testing has been reported to substantiated. Provided the possibility of conyield negative results in cases of C. albidus infection [8] .
tamination of clinical specimens with such species is In both cases presented here the in vitro latex agexcluded, the potential of saprobic cryptococcal species glutination tests for cryptococcal antigen were negative.
to infect AIDS patients cannot be eliminated. The treatment of choice for the more common men-
The epidemic of AIDS has set new challenges to ingeal and extrameningeal cryptococcal infections due the clinician and the mycologist by broadening and to C. neoformans is amphotericin B and flucytosine.
intensifying studies on the emerging opportunistic inThis combination therapy has been reported to control fections. It has been estimated that for every million 90% of patients, including those with AIDS, whose AIDS patients 50 000-100 000 will contract crypto-CSF was sterile after 2 weeks of treatment [15] [16] [17] [18] [19] [20] [21] .
coccosis [2] . The unusual emerging cryptococcal, as Treatment regimens comprising amphotericin B comwell as other, fungal infections [26] will require novel bined with fluconazole have been found to be effective strategies in the surveillance of patients at risk, in and well tolerated in first-line therapy in patients with preventive measures and in basic and applied research. AIDS-associated meningeal cryptococcosis [22] .
Both our patients were treated with the conventional combination therapy of amphotericin B and flucytosine.
